Compositions and methods for eliciting an immune response to escape mutants of targeted therapies

Details for Australian Patent Application No. 2006268333 (hide)

Owner GlobeImmune, Inc.

Inventors Franzusoff, Alex; Apelian, David; Rodell, Timothy C.

Agent FB Rice

Pub. Number AU-B-2006268333

PCT Pub. Number WO2007/008780

Priority 60/698,381 11.07.05 US

Filing date 10 July 2006

Wipo publication date 18 January 2007

Acceptance publication date 14 June 2012

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/008780 Priority application(s): WO2007/008780

14 June 2012 Application Accepted

  Published as AU-B-2006268333

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268334-Handle for a shaving implement

2006268327-Transgenic mice carrying Hp-2 gene and uses as models for vascular diseases